Navigation Links
Should doctors tell patients about expensive, unfunded drugs?

It is unethical and paternalistic for doctors to withhold information from patients about new drugs that are not yet publicly funded, say researchers in this week's BMJ.

New drugs may be more effective than existing treatments, but many are very expensive and may not be available through publicly funded health schemes.

This raises several ethical dilemmas for doctors. Is it reasonable to ask a patient to finance the full cost of their treatment when it is not provided by government? Would it be unethical to raise the option of treatment with an unsubsidised drug?

Researchers surveyed 184 Australian cancer specialists about their opinions and practices regarding potentially useful but unsubsidised drugs.

A large proportion said they would not discuss an expensive drug with a patient if it were not subsidised because of potential psychological and emotional effects that these discussions might have on patients and their families. The survey also found that these discussions were stressful for clinicians.

But the authors argue that this practice fails to respect autonomy and may not be in the patient's best interests. They believe that withholding information on the basis of what a patient would want is "a dangerous medical path to unjustified paternalism."

A further ethical issue concerns the cost of publicly funding newer, expensive treatments, they write. This is an urgent question of distributing limited resources fairly that faces not just new drugs, but many forms of modern technological care. "The gap between what we can do and what we can afford will continue to grow, at a personal and community level."

The issue of accessing new expensive drugs has no easy solution, they say. Nevertheless, it seems unreasonable to withhold information from a patient about any potentially beneficial treatment because of concerns about capacity to pay, even if these discussions cause distress for some patients.

Society at large should discuss whether new, high-cost drugs should be publicly funded, they conclude.


'"/>

Source:BMJ-British Medical Journal


Related biology news :

1. Survey reveals women and doctors arent talking about HPV
2. Efficiency, not more doctors, is the prescription for aging population
3. Stanford doctors advance in bid to turn mice stem cells into blood vessels
4. Patients and their doctors have different perceptions about HIV and its treatment
5. Free drug samples influence prescribing, say one in three doctors
6. Reminding doctors which antibiotics to prescribe cuts C. difficile infection rates
7. Genes and biomarkers that allow doctors to choose the right therapy for the right patient
8. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
9. Potential Cure for Lymphoma in HIV patients
10. Ophthalmologists implant five patients with artificial silicon retina microchip
11. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/3/2016)... 2016  2016FLEX, organized by FlexTech, a SEMI ... in flexible, hybrid and printed electronics. More than ... have gathered for short courses, technical session, exhibits, ... The Flex Conference celebrates its 15 th ... organizations, and universities contributing to the adoption of ...
(Date:3/2/2016)... DUBLIN , March 2, 2016 /PRNewswire/ ... the addition of the "Global Biometrics ... to their offering. --> ... the "Global Biometrics as a Service ... --> Research and Markets ...
(Date:3/1/2016)... and SAN FRANCISCO , March ... HYPR Corp. and BitGo, Inc. extends biometric authentication to ... and private keys. Bitcoin transactions ... billion per month in digital assets with over 10,000 ... for any startup. HYPR enables enterprises to keep encrypted ...
Breaking Biology News(10 mins):
(Date:4/29/2016)... , ... April 29, 2016 , ... Intelligent Implant Systems ... the FDA via 510(k) for sale in the United States. These components expand ... thoraco-lumbar fusions. With one-level sales beginning in October of 2015, the company has ...
(Date:4/28/2016)... Hill, Conn. (PRWEB) , ... April 28, 2016 ... ... of financing and ongoing support for Connecticut's innovative, growing companies, today announced the ... digital health and financial technology (fintech) companies. , “VentureClash looks to ...
(Date:4/27/2016)... ... , ... Cambridge Semantics, the leading provider of Smart Data analytic ... been named to The Silicon Review’s “20 Fastest Growing Big Data Companies of 2016.” ... the needs of end users facing some of the most complex data challenges in ...
(Date:4/27/2016)... British Columbia , April 27, 2016 /PRNewswire/ ... oder "NanoStruck") (CSE: NSK) (OTCPink: NSKQB) ( ... im Anschluss an ihre Pressemitteilung vom 13. August ... erhalten hat, ihre Finanzen um zusätzliche 200.000.000 Einheiten ... 4.000.000 Kanadische Dollar zu bringen. Davon wurden 157.900.000 ...
Breaking Biology Technology: